Literature DB >> 15783113

Primary anaplastic large cell lymphoma of the testis.

J Azúa-Romeo1, R Alvarez-Alegret, P Serrano, E Mayayo.   

Abstract

Anaplastic large cell lymphoma (ALCL) was first described by Stein et al. in 1985, at that time neoplastic cells were labeled by the monoclonal antibody CD30. ALCL was included as a differentiate entity in the reviewed Kiel and REAL classification. ALCL carries the t (2; 5) (p23; q35) translocation; the absence of ALK kinase from normal lymphoid cells indicates that immunohistochemical expression of ALK is specific for the (2; 5) translocation. This disease is characterized by a diffuse proliferation of large anaplastic cells with kidney-shaped/horse-shoe nuclei. A distinguishing feature is a perinuclear eosinophilic region that represents a prominent Golgi apparatus. These cells are named hallmark-cells being almost pathognomonic. Immunohistochemically the most important features are that tumor cells consistently express CD30 and EMA on the cell membrane and in the Golgi region, while ALK immunostaining is usually both, cytoplasmic and nuclear. To our knowledge only two cases of primary ALCL of the testis have been reported. Hereby we present a case of a typical ALCL expressing ALK and CD30, which presented with subcutaneous nodules and bilateral testicular mass, without systemic involvement.

Entities:  

Mesh:

Year:  2004        PMID: 15783113     DOI: 10.1007/s11255-004-0750-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  11 in total

Review 1.  CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

Authors:  H Stein; H D Foss; H Dürkop; T Marafioti; G Delsol; K Pulford; S Pileri; B Falini
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

2.  Neutrophil-rich Ki-1-positive anaplastic large cell lymphoma presenting as a testicular mass.

Authors:  M Akhtar; F al-Dayel; K Siegrist; A Ezzat
Journal:  Mod Pathol       Date:  1996-08       Impact factor: 7.842

3.  Updated Kiel classification for lymphomas.

Authors:  A G Stansfeld; J Diebold; H Noel; Y Kapanci; F Rilke; G Kelényi; C Sundstrom; K Lennert; J A van Unnik; O Mioduszewska
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

4.  ALK+ lymphoma: clinico-pathological findings and outcome.

Authors:  B Falini; S Pileri; P L Zinzani; A Carbone; V Zagonel; C Wolf-Peeters; G Verhoef; F Menestrina; G Todeschini; M Paulli; M Lazzarino; R Giardini; A Aiello; H D Foss; I Araujo; M Fizzotti; P G Pelicci; L Flenghi; M F Martelli; A Santucci
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

5.  Lymphomas expressing ALK fusion protein(s) other than NPM-ALK.

Authors:  B Falini; K Pulford; A Pucciarini; A Carbone; C De Wolf-Peeters; J Cordell; M Fizzotti; A Santucci; P G Pelicci; S Pileri; E Campo; G Ott; G Delsol; D Y Mason
Journal:  Blood       Date:  1999-11-15       Impact factor: 22.113

Review 6.  ALK-positive lymphoma: a single disease with a broad spectrum of morphology.

Authors:  D Benharroch; Z Meguerian-Bedoyan; L Lamant; C Amin; L Brugières; M J Terrier-Lacombe; E Haralambieva; K Pulford; S Pileri; S W Morris; D Y Mason; G Delsol
Journal:  Blood       Date:  1998-03-15       Impact factor: 22.113

7.  Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules.

Authors:  H D Foss; I Anagnostopoulos; I Araujo; C Assaf; G Demel; J A Kummer; M Hummel; H Stein
Journal:  Blood       Date:  1996-11-15       Impact factor: 22.113

8.  CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology.

Authors:  L Brugières; M C Deley; H Pacquement; Z Meguerian-Bedoyan; M J Terrier-Lacombe; A Robert; C Pondarré; G Leverger; C Devalck; C Rodary; G Delsol; O Hartmann
Journal:  Blood       Date:  1998-11-15       Impact factor: 22.113

9.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

Authors:  H Stein; D Y Mason; J Gerdes; N O'Connor; J Wainscoat; G Pallesen; K Gatter; B Falini; G Delsol; H Lemke
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  1 in total

1.  Unusual presentation of anaplastic large cell lymphoma with clinical course mimicking fever of unknown origin and sepsis: autopsy study of five cases.

Authors:  Marina B Mosunjac; J Bruce Sundstrom; Mario I Mosunjac
Journal:  Croat Med J       Date:  2008-10       Impact factor: 1.351

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.